| Literature DB >> 32500721 |
Lauren S Ranard1, Justin A Fried1, Marwah Abdalla1, D Edmund Anstey1, Raymond C Givens1, Deepa Kumaraiah1, Susheel K Kodali1,2, Koji Takeda3, Dimitrios Karmpaliotis1,2, LeRoy E Rabbani1, Gabriel Sayer1, Ajay J Kirtane1,2, Martin B Leon1,2, Allan Schwartz1, Nir Uriel1, Amirali Masoumi1.
Abstract
The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic. It has spread to >187 countries with a rapidly growing number of affected patients. Underlying cardiovascular disease is associated with more severe manifestations of COVID-19 and higher rates of mortality. COVID-19 can have both primary (arrhythmias, myocardial infarction, and myocarditis) and secondary (myocardial injury/biomarker elevation and heart failure) cardiac involvement. In severe cases, profound circulatory failure can result. This review discusses the presentation and management of patients with severe cardiac complications of COVID-19 disease, with an emphasis on a Heart-Lung team approach in patient management. Furthermore, it focuses on the use of and indications for acute mechanical circulatory support in cardiogenic and/or mixed shock.Entities:
Keywords: acute coronary syndrome; cardiovascular diseases; coronavirus; heart failure; myocardial infarction; shock, cardiogenic
Mesh：
Substances：
Year: 2020 PMID： 32500721 PMCID： PMC8126417 DOI： 10.1161/CIRCHEARTFAILURE.120.007220
Source DB: PubMed Journal: Circ Heart Fail ISSN： 1941-3289 Impact factor: 8.790